Crescent Biopharma Grants 129,075 Stock Options to 5 Employees

Crescent Biopharma, Inc. announced that its Compensation Committee approved the grant of options to purchase an aggregate of 129,075 ordinary shares to five non-executive employees. These equity inducement awards were made under the Company's 2025 Employment Inducement Incentive Award Plan and were material to the employees' acceptance of employment. The options have a 10-year term and an exercise price of $18.52, based on the closing price on May 11, 2026. Vesting occurs over four years, with one-fourth vesting on the first anniversary and one-forty-eighth monthly thereafter, subject to continuous service.